Bharat Immunologicals financial leverage is the degree to which the firm utilises its fixed-income securities. Companies with high leverage are usually considered to be at financial risk. Bharat Immunologicals financial risk is the risk to Bharat Immunologicals stockholders that is caused by an increase in debt. In other words with a high degree of financial leverage come high interest payments which usually reduces Earnings Per Share (EPS). Check also Trending Equities.
Bharat Immunologicals Financial Leverage Rating
Total Macroaxis Rating
Average S&P Rating
Bharat Immunologicals Debt to Cash Allocation
The company has accumulated zero balance in total debt with debt to equity ratio (D/E) of 3.8 implying the company greatly relies on financing operations through barrowing. Bharat Immunologicals has Current Ratio of 1.75 which is within standard range for the sector.